[Médecins Sans Frontières] In this briefing document, MSF analyses provisions related to transparency, intellectual property (IP), research and development (R&D), antimicrobial resistance (AMR), stockpiling, and access and benefit sharing in the accord zero draft. The definitions and scope of these provisions, as well as the nature of obligations contained therein, are key to determining the extent to which the accord can meaningfully address inequity.